These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 8506803)

  • 41. Dose-dependent effect and side-effect of prostaglandin E1 in erectile dysfunction.
    Schramek P; Waldhauser M
    Br J Clin Pharmacol; 1989 Nov; 28(5):567-71. PubMed ID: 2686740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction.
    Kunelius P; Lukkarinen O
    Int J Impot Res; 1999 Feb; 11(1):21-4. PubMed ID: 10098949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preliminary results of a comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction.
    Martinez-Piñeiro L; Lopez-Tello J; Alonso Dorrego JM; Cisneros J; Cuervo E; Martinez-Piñeiro JA
    J Urol; 1995 May; 153(5):1487-90. PubMed ID: 7714974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
    Bratus D; Hlebic G; Hajdinjak T
    Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The intracavernous injection of Edex (prostaglandin E1) in the treatment of erectile impotence in persons in older age groups].
    Gorilovskiĭ LM
    Urol Nefrol (Mosk); 1996; (6):31-3. PubMed ID: 9036606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prostaglandin E1 in the treatment of erectile insufficiency. Comparison of efficacy and tolerance based on different etiologies].
    Desvaux P; Mimoun S
    J Urol (Paris); 1994; 100(1):17-22. PubMed ID: 7916373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Does prostaglandin El (PGE1) help restoration of spontaneous erections?].
    Thiounn N; Flam T; Zerbib M; Debré B
    J Urol (Paris); 1993; 99(3):136-8. PubMed ID: 7745271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Classification of patterns of nocturnal penile tumescence with continuous monitoring of penile rigidity: analysis of various factors affecting erection].
    Yasumoto R; Kawano M; Tsurusaki K; Yoneda Y; Ishii K; Khono T; Kumata N; Fukui J; Hayashi S; Tsujino T; Umeda M
    Hinyokika Kiyo; 1996 Apr; 42(4):285-8. PubMed ID: 8693961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of effects following the intracorporeal injection of papaverine and prostaglandin E1.
    Chen JK; Hwang TI; Yang CR
    Br J Urol; 1992 Apr; 69(4):404-7. PubMed ID: 1581812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy.
    Hoshi K; Mizushima Y; Kiyokawa S; Yanagawa A
    Drugs Exp Clin Res; 1986; 12(8):681-5. PubMed ID: 3757764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prostaglandin treatment in neurological patients with erectile dysfunction].
    Conejero Sugrañes J; Muñoz Villellas A; Sarrias Lorenz F; Ramírez Garceran L
    Arch Esp Urol; 2002; 55(1):63-8. PubMed ID: 11957754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prostaglandin E1 (PGE1) in diagnosis and long-term therapy of erectile dysfunction].
    Derouet H; Weirauch A; Bewermeier H
    Urologe A; 1996 Jan; 35(1):62-7. PubMed ID: 8851852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraurethral prostaglandin improves quality of vacuum erection therapy.
    John H; Lehmann K; Hauri D
    Eur Urol; 1996; 29(2):224-6. PubMed ID: 8647152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Non-surgical treatment of impotence].
    Otani T
    Hinyokika Kiyo; 1991 Nov; 37(11):1367-72. PubMed ID: 1767761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical and hemodynamic effects of lipo PGE1 in cerebral infarction].
    Korosue K; Kondoh T; Ishikawa A; Suzuki H; Nagao T; Tamaki N; Matsumoto S
    No Shinkei Geka; 1988 Jun; 16(7):819-26. PubMed ID: 3221965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impotence evaluated by the use of prostaglandin E1.
    Hwang TI; Yang CR; Wang SJ; Chang CL; Tzai TS; Chang CH; Wu HC
    J Urol; 1989 Jun; 141(6):1357-9. PubMed ID: 2724434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progress in the prostaglandin E1-therapy of the intermittent claudication by means of bolus injections of LIPO-prostaglandin E1 (LIPO-PGE1).
    Scheffler P; Gross J; Markwirth T; Maier J; Schieffer H
    Eur J Clin Pharmacol; 1996; 51(3-4):235-9. PubMed ID: 9010691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.